Featured Research

from universities, journals, and other organizations

Businesses not prepared for pandemics and other disasters

Date:
February 21, 2013
Source:
Saint Louis University Medical Center
Summary:
In light of the recent influenza outbreak, a new study finds that majority of businesses are not prepared for a pandemic.

A recent study by Saint Louis University researchers found that majority of businesses are not adequately prepared for many types of disasters, especially biological events such as a pandemic.

Findings from this study are particularly timely given that the U.S. is currently in the midst of an influenza outbreak, one of the worst in the decade.

Terri Rebmann, Ph.D., associate professor at SLU College for Public Health and Social Justice was the principal investigator of the study that examined how often U.S. businesses, both healthcare and non-healthcare companies, prepare for disasters and biological events.

Rebmann said businesses need to improve their disaster plans for biological events so that they are able to minimize the impact of disasters and continue daily operations. "One of the key findings from the study was that about 60 percent businesses reported they have a policy that encourages their ill staff to stay home, but about 40 percent responded that the business has a culture that encourages staff to work when they are sick," said Rebmann. "There's a disconnect between written policies versus what the business culture encourages. This can contribute to disease spread in the business setting, especially among healthcare agencies."


Story Source:

The above story is based on materials provided by Saint Louis University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Saint Louis University Medical Center. "Businesses not prepared for pandemics and other disasters." ScienceDaily. ScienceDaily, 21 February 2013. <www.sciencedaily.com/releases/2013/02/130221141119.htm>.
Saint Louis University Medical Center. (2013, February 21). Businesses not prepared for pandemics and other disasters. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2013/02/130221141119.htm
Saint Louis University Medical Center. "Businesses not prepared for pandemics and other disasters." ScienceDaily. www.sciencedaily.com/releases/2013/02/130221141119.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins